DIN 02526670 — TRIKAFTA 37.5 MG; 25 MG; 50 MG; 75 MG
TRIKAFTA is a tablet of Elexacaftor / Tezacaftor / Ivacaftor marketed by VERTEX PHARMACEUTICALS (CANADA) INCORPORATED. The full Elexacaftor / Tezacaftor / Ivacaftor monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02526670
- Brand name
- TRIKAFTA
- Active ingredient
- Elexacaftor / Tezacaftor / Ivacaftor
- Strength
- 37.5 MG; 25 MG; 50 MG; 75 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Cystic fibrosis transmembrane conductance regulator (CFTR) corrector and potentiator combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Elexacaftor / Tezacaftor / Ivacaftor products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02542285 | TRIKAFTA | 40 MG; 60 MG; 80 MG; 59.5 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02517140 | TRIKAFTA | 75 MG; 50 MG; 100 MG; 150 MG | TABLET | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |
| 02542277 | TRIKAFTA | 75 MG; 75 MG; 100 MG; 50 MG | GRANULES | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED | MARKETED |